Company news

Nautilus Biotechnology, Inc. news in 2026

Nautilus Biotechnology, Inc.'s news releases, calls and decks from 2026, newest first.

View company

Nautilus to Measure Proteoforms Driving Alzheimer’s Disease and Cancer in ARPA-H-Funded SEEDS Consortium

October 27, 2026

Nautilus Biotechnology Reports Third Quarter 2026 Financial Results

October 27, 2026

Nautilus Biotechnology to Announce Third Quarter 2026 Financial Results on October 27, 2026

October 15, 2026

Nautilus Biotechnology Reports Second Quarter 2026 Financial Results

July 28, 2026

Nautilus Biotechnology to Announce Second Quarter 2026 Financial Results on July 28, 2026

July 8, 2026

Nautilus Biotechnology Reports First Quarter 2026 Financial Results

April 28, 2026

Nautilus Biotechnology to Announce First Quarter 2026 Financial Results on April 28, 2026

April 8, 2026

Nautilus Biotechnology to Participate in the Investor Summit Group Virtual Conference

March 24, 2026

Investor Summit Announces Q1 Presenter Line Up (Presentations 3/25, 1-on-1s 3/26)

March 20, 2026

Nautilus Biotechnology Announces Baylor College of Medicine as First Early Access Program Customer for Voyager Platform

March 17, 2026

Nautilus Biotechnology Appoints Proteomics Commercial Leader Amber Faust as Vice President of Sales

March 1, 2026

Nautilus Biotechnology Reports Fourth Quarter and Fiscal Year 2025 Financial Results

February 25, 2026

Nautilus Biotechnology Unveils Voyager Platform, Enabling Single-Molecule Iterative Mapping, at US HUPO 2026

February 23, 2026

Nautilus Biotechnology to Participate in the TD Cowen 46th Annual Health Care Conference

February 19, 2026

Nautilus Biotechnology to Announce Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026

February 5, 2026

Nautilus Biotechnology and Weill Cornell Medicine-Qatar Collaborate with The Michael J. Fox Foundation to Advance Single-Molecule Proteomics Research in Parkinson’s Disease

January 28, 2026

Nautilus Biotechnology Launches Early Access Program for Novel Single-Molecule Proteomics Platform, Starting with Tau Proteoforms Assay

January 8, 2026

Calls in 2026

Decks in 2026